A23V 2250/304
Choline
A23V2250/304 (Choline) appears on 7 US grants and 14 published applications in this corpus.
Search patents in A23V- Granted patents
- 7
- Published applications
- 14
- Assignees
- 9
- Inventors
- 29
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 1 | 1 |
| 2021 | 1 | 3 |
| 2022 | 1 | 0 |
| 2023 | 1 | 3 |
| 2024 | 1 | 1 |
| 2025 | 1 | 1 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Nutritional compositions and infant formula for promoting de novo myealination21 Jul 2026US 12,685,331 B2Societe des Produits Nestle S. A.
- Food supplement and composition comprising choline butyrate salt and/or butyrylcholine4 Mar 2025US 12,239,616 B2Abergavenny NV
- Lipid emulsion for parenteral nutrition comprising GPC24 Dec 2024US 12,171,866 B2Baxter Healthcare S. A.
- Food supplement and composition comprising choline butyrate salt and/or butyrylcholine9 May 2023US 11,642,322 B2Abergavenny NV
- Method for producing a ready-to-use, long-life infant milk27 Dec 2022US 11,533,942 B2Even Sante Industrie
- Parenteral nutrition formulation2 Apr 2026US 2026/0090983 A1Baxter Healthcare S. A.
- Medicine for steatohepatitis13 Feb 2025US 2025/0049735 A1The University of Tokyo
- Lipid emulsion for parenteral nutrition comprising gpc21 Nov 2024US 2024/0382414 A1Baxter Healthcare S. A.
- Metabolic therapy of cancer19 Oct 2023US 2023/0329304 A1Aminovita S.L.
- Food supplement and composition comprising choline butyrate salt and/or butyrylcholine13 Jul 2023US 2023/0218551 A1Abergavenny NV
Most cited
By later US patents